Tag: FDA
-
FDA Approves Most Potent Weight Loss Drug Yet
[ad_1] Weight loss drugs have dominated the headlines over the past year, and now there’s a new medication that may be the most effective one yet. On Nov. 11, the U.S. Food and Drug Administration (FDA) approved tirzepatide (which will be sold under the brand name Zepbound), to treat overweight and obesity. Made by Eli…
-
FDA approves Zepbound, new Wegovy rival : Shots
[ad_1] Drugmaker Eli Lilly & Co. received Food and Drug Administration approval for an obesity drug called Zepbound that will be a rival to Novo Nordisk’s Wegovy. Darron Cummings/AP hide caption toggle caption Darron Cummings/AP Drugmaker Eli Lilly & Co. received Food and Drug Administration approval for an obesity drug called Zepbound that will be…
-
FDA proposes banning brominated vegetable oil as food additive : NPR
[ad_1] A sign for the U.S. Food and Drug Administration is displayed outside its offices in Silver Spring, Md., on Dec. 10, 2020. The FDA says it’s considering banning brominated vegetable oil, a food additive. Manuel Balce Ceneta/AP hide caption toggle caption Manuel Balce Ceneta/AP A sign for the U.S. Food and Drug Administration is…
-
FDA warns WanaBana fruit pouches contain high lead levels, endangering children : NPR
[ad_1] This photo provided by the U.S. Food and Drug Administration on Oct. 28, 2023, shows a WanaBana apple cinnamon fruit puree pouch. AP hide caption toggle caption AP This photo provided by the U.S. Food and Drug Administration on Oct. 28, 2023, shows a WanaBana apple cinnamon fruit puree pouch. AP The Food and…
-
The FDA issues warning for eyedrop products due to infection risk : NPR
[ad_1] The FDA warned consumers to stop using eyedrop products from six different brands on Wednesday after agency investigators found bacteria contamination at a manufacturing site. Manuel Balce Ceneta/AP hide caption toggle caption Manuel Balce Ceneta/AP The FDA warned consumers to stop using eyedrop products from six different brands on Wednesday after agency investigators found…
-
FDA Confirms IM Doc Concerns About Pharmacies Pushing Covid Boosters + Other Vaccines in Same Visit
[ad_1] We recently had a debate in the comments section about the (de)merits of getting multiple vaccinations at once (as in ones designed, safety-tested and approved as individual shots). Reader Daryl reported his contrasting experience with the positive reader reports about getting a Novavax booster, which should by virtue of its more traditional design, cause…
-
FDA Moves to Ban Sale of Vuse Menthol Vapes
[ad_1] The Food and Drug Administration has ordered R.J. Reynolds to stop selling its popular Vuse Alto menthol e-cigarettes, a decision Reynolds immediately said it would challenge in court. On Thursday, the agency denied applications by Reynolds to keep its top-selling menthol products permanently on the market, saying that the company did not meet the…
-
Why It Took So Long for the FDA to Tackle a Cold Medicine
[ad_1] Dr. Leslie Hendeles began prodding the Food and Drug Administration to reject a decongestant in cold medicines when he had a mop of curly red hair and Bill Clinton had just become president. By the time opposition to the drug had coalesced, Dr. Hendeles was appearing, at age 80, as an expert to testify…
-
Popular nasal decongestant doesn’t actually relieve congestion, FDA advisers say : NPR
[ad_1] Sudafed and other common nasal decongestants containing pseudoephedrine are on display behind the counter at Hospital Discount Pharmacy in Edmond, Okla., Jan. 11, 2005. AP hide caption toggle caption AP Sudafed and other common nasal decongestants containing pseudoephedrine are on display behind the counter at Hospital Discount Pharmacy in Edmond, Okla., Jan. 11, 2005.…
-
FDA approves COVID shots from Moderna and Pfizer : Shots
[ad_1] Another round of COVID-19 vaccines is on the way. The Food and Drug Administration approved vaccines from Pfizer and Moderna that target an omicron subvariant called XBB.1.5. Vaccination campaigns, like this one in San Rafael, Calif., in 2022, could resume soon. Justin Sullivan/Getty Images hide caption toggle caption Justin Sullivan/Getty Images Another round of…